Jonathan Chung to Neoplasms, Germ Cell and Embryonal
This is a "connection" page, showing publications Jonathan Chung has written about Neoplasms, Germ Cell and Embryonal.
Connection Strength
0.203
-
Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart. Oncologist. 2019 04; 24(4):e142-e145.
Score: 0.163
-
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. Eur Urol. 2019 01; 75(1):201-203.
Score: 0.040